1 – 10 of 16
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2013
-
Mark
Retigabine as add-on treatment of refractory epilepsy– a cost-utility study in a swedish setting
(
- Contribution to journal › Article
- 2012
-
Mark
The Cost Effectiveness of Newer Epilepsy Treatments: A Review of the Literature on Partial-Onset Seizures.
(
- Contribution to journal › Scientific review
-
Mark
Economic Evaluation of Smoking-Cessation Therapies: A Critical and Systematic Review of Simulation Models.
(
- Contribution to journal › Scientific review
- 2011
-
Mark
Current and future avoidable cost of smoking - Estimates for Sweden 2007.
(
- Contribution to journal › Article
-
Mark
Economic value of smoking cessation therapies: a critical and systematic review of simulation-generated evidence
(
- Contribution to journal › Scientific review
- 2009
-
Mark
Health Production
2009)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Varenicline – The cost-utility of an additional 12-week course of varenicline for the maintenance of smoking abstinence
2009) In Journal of Evaluation in Clinical Practice(
- Contribution to journal › Article
- 2008
-
Mark
Sickness absence from work
2008) p.115-141(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Early retirement
2008) p.143-199(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Changes in the health status of the population
2008)(
- Book/Report › Book